Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sutro Biopharma stock

Learn how to easily invest in Sutro Biopharma stock.

Sutro Biopharma is a biotechnology business based in the US. Sutro Biopharma shares (STRO) are listed on the NASDAQ and all prices are listed in US Dollars. Sutro Biopharma employs 259 staff and has a trailing 12-month revenue of around $69.8 million.

How to buy Sutro Biopharma stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – STRO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Sutro Biopharma stock price (NASDAQ: STRO)

Use our graph to track the performance of STRO stocks over time.

Sutro Biopharma shares at a glance

Information last updated 2023-02-02.
Latest market close$6.87
52-week range$3.33 - $10.15
50-day moving average $7.52
200-day moving average $6.21
Wall St. target price$22.13
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.47

Buy Sutro Biopharma stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Sutro Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sutro Biopharma price performance over time

Historical closes compared with the close of $6.87 from 2023-02-06

1 week (2023-01-31) -5.11%
1 month (2023-01-06) -16.32%
3 months (2022-11-07) -8.76%
6 months (2022-08-05) 19.27%
1 year (2022-02-03) -28.88%
2 years (2021-02-05) -73.94%
3 years (2020-02-07) 11.75
5 years (2018-02-03) N/A

Sutro Biopharma financials

Revenue TTM $69.8 million
Gross profit TTM $-42,520,000
Return on assets TTM -18.56%
Return on equity TTM -47.82%
Profit margin -175.85%
Book value $4.21
Market capitalisation $421.3 million

TTM: trailing 12 months

Sutro Biopharma share dividends

We're not expecting Sutro Biopharma to pay a dividend over the next 12 months.

Sutro Biopharma share price volatility

Over the last 12 months, Sutro Biopharma's shares have ranged in value from as little as $3.33 up to $10.15. A popular way to gauge a stock's volatility is its "beta".

STRO.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sutro Biopharma's is 0.9323. This would suggest that Sutro Biopharma's shares are less volatile than average (for this exchange).

Sutro Biopharma overview

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc.

Frequently asked questions

What percentage of Sutro Biopharma is owned by insiders or institutions?
Currently 5.654% of Sutro Biopharma shares are held by insiders and 89.525% by institutions.
How many people work for Sutro Biopharma?
Latest data suggests 259 work at Sutro Biopharma.
When does the fiscal year end for Sutro Biopharma?
Sutro Biopharma's fiscal year ends in December.
Where is Sutro Biopharma based?
Sutro Biopharma's address is: 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Sutro Biopharma's ISIN number?
Sutro Biopharma's international securities identification number is: US8693671021
What is Sutro Biopharma's CUSIP number?
Sutro Biopharma's Committee on Uniform Securities Identification Procedures number is: 869367102

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site